Emerging CSF Biomarkers for Disease Activity and Progression in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
JAMA Neurol 2024 Mar 11;[EPub Ahead of Print], AH Cross, JM Gelfand, S Thebault, JL Bennett, HC von Büdingen, B Cameron, R Carruthers, K Edwards, R Fallis, R Gerstein, PS Giacomini, B Greenberg, DA Hafler, C Ionete, UW Kaunzner, L Kodama, C Lock, EE Longbrake, B Musch, G Pardo, F Piehl, MS Weber, S Yuen, T Ziemssen, G Bose, MS Freedman, VG Anania, A Ramesh, RC Winger, X Jia, A Herman, C Harp, A Bar-OrFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.